Persistent infection of macaques with simian-human immunodeficiency viruses
about
Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentationThe human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factorsHuman immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infectionMutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer.Macaques as model hosts for studies of HIV-1 infectionMolecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env.Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing.Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2)In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeysInduction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina).Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo.Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo.Characterization of primary isolate-like variants of simian-human immunodeficiency virusGeneration of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaquesEnvelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge.Pathogenicity and rapid growth kinetics of feline immunodeficiency virus are linked to 3' elements.CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques.Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropismAdaptation of HIV-1 to cells expressing rhesus monkey TRIM5αMolecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage.Non-human primate models for AIDS vaccine research.Adaptation of subtype a human immunodeficiency virus type 1 envelope to pig-tailed macaque cellsBimodal AIDS vaccine approach: induction of cellular as well as humoral immunity can protect from systemic infection.Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo.DNA vaccines against human immunodeficiency virus type 1 in the past decade.Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaques.An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeysA chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys.Molecularly cloned SHIV-CN97001: a replication-competent, R5 simian/human immunodeficiency virus containing env of a primary Chinese HIV-1 clade C isolate.The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules.
P2860
Q24656958-EEAA5642-8E2E-4083-BD4F-16F70EF9098FQ24670601-DADAE810-3468-42F0-AA3B-055F970AF5BDQ28646867-DFE01C4A-8773-4E7B-B11E-76FE2C713292Q30368471-EC653872-D4D9-4AD5-92FE-88A9DFBF27ACQ30653348-E2A51CE1-9DCD-43CB-A601-041DA2CD1CA6Q33372270-1AD84DB1-E3D7-4E76-90E5-BED2EEFB737CQ33382060-5B937452-D982-452F-8B5C-349534EE03A1Q33638829-353D8BAD-68DA-4C38-86D3-20A2D57E92E5Q33640055-2AC7D587-E626-4227-9A2D-4E2D80AAB218Q33640139-C6FF25E7-CF59-4B08-869D-93C55AED19A8Q33783369-378F9D0E-5D6C-417E-9B10-079A2D5FCD00Q33783516-FC36079C-ED76-494C-BE25-0FC0D7706FCFQ33785114-0464B5F7-F9CD-499A-995E-A669262C7078Q33794744-A13E3077-4686-4742-9200-DBF005FE62E9Q33807885-48858484-626F-438F-B4A3-2E9A8A9A2DFAQ33813212-FCD01459-C82C-422D-A928-D0B4E0053FCBQ33813253-0FE19904-C325-48C1-BA0B-8AE8D79B0056Q33821658-C5814A67-01A0-4E0D-A9AD-A86E3B2EFF38Q33825229-BCD18FDF-2926-4D68-B7F6-CAFED64CCDA3Q33826773-FFF2798B-0553-4B56-B315-36DE9A87D493Q33839485-DA0E2C37-CB09-4426-91D9-B73DF40C6DA6Q33852768-8AFAF8AD-36C3-4D6C-8A07-5E9E2789472AQ34009788-4E7B4D28-9C21-4765-87D6-64D78B6872D5Q34070178-DA3C8561-7E85-4F5E-A3EC-35A3686AFA2AQ34154693-DB259077-E2CC-4883-99DD-F4D6BCDBC68FQ34288181-11F37960-CE37-4FB6-81FA-F975D6271E6CQ34338411-88A6AB91-C29A-4126-A663-58FC9FAE6246Q34715769-A6DBD1ED-96F5-4FAF-BECE-68EE534B3A84Q35076897-26968576-1FE9-41C9-A291-FA8C46B2F356Q35198510-D5FC3312-CE9A-4D0E-A95B-4F73D748D1E5Q35383070-8A601DBA-E38C-47FA-99FB-EFC67E21CA96Q35745831-17E82004-C76C-422C-8DE3-9B578F1F352EQ35821368-8AB9D436-22CE-4596-A01E-A31794B01FC5Q35860563-92F17CC0-8D7B-47F0-A80B-9DD377765EFDQ35870467-C82DDDE2-3F34-4D42-995A-6D422D99EC88Q35871440-C4EAD2EB-4ADD-4A2D-BDE2-04D79C827AA6Q35873115-4821CCC7-139C-4445-B4DE-8419804EA125Q35885915-25AA8A6D-7C4D-432F-A8CB-79E5353D7628Q36073984-BD9C746E-9E2D-4261-9EDC-6C40B0C1BA67Q36377062-8C6C141C-A457-4460-9223-261B68F37EC4
P2860
Persistent infection of macaques with simian-human immunodeficiency viruses
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Persistent infection of macaques with simian-human immunodeficiency viruses
@ast
Persistent infection of macaques with simian-human immunodeficiency viruses
@en
type
label
Persistent infection of macaques with simian-human immunodeficiency viruses
@ast
Persistent infection of macaques with simian-human immunodeficiency viruses
@en
prefLabel
Persistent infection of macaques with simian-human immunodeficiency viruses
@ast
Persistent infection of macaques with simian-human immunodeficiency viruses
@en
P2093
P2860
P1433
P1476
Persistent infection of macaques with simian-human immunodeficiency viruses
@en
P2093
J G Sodroski
J Ranchalis
N L Letvin
P2860
P304
P407
P50
P577
1995-11-01T00:00:00Z